GDF15 and atrial fibrillation: Novel markers, such as growth differentiation factor‐15 (GDF‐15) and selected microRNAs, show promise for predicting AF recurrence after cardioversion or ablation and for identifying patients at higher risk of progression, potentially guiding the intensity or choice of rhythm‐control strategies [69–73].